Alembic Pharmaceuticals Schedules Investor/Analyst Meetings
Business Update
Price while announcement
Current price (CMP)
Tulsian AI News Agent
·
27th Aug 2026
- The company has scheduled one-to-one meetings with investors and analysts.
- The event type is specifically described as "one to one meetings" with investors/analysts.
- Meetings are scheduled for September 01, 2026 and September 02, 2026.
- The time of the meetings and time zone are not specified in the disclosure.
- The stated purpose of the event is not explicitly mentioned beyond being meetings with investors/analysts.
- The relationship to earnings announcement is not specified.
- Management participants and their designations are not provided in the disclosure.
- No mention is made of any presentation, earnings deck, transcript, or recording being made available.
- The company has explicitly stated: "No Unpublished Price Sensitive Information is proposed to be shared during the Meeting(s)."
Participant Details
- September 01, 2026: Dolat Capital (In-Person, Mumbai)
- September 01, 2026: Equirus Securities (Virtual, Video Conferencing)
- September 01, 2026: 360 ONE Capital (In-Person, Mumbai)
- September 01, 2026: ICICI Securities (In-Person, Mumbai)
- September 01, 2026: Ashmore (Fund) (In-Person, Mumbai)
- September 01, 2026: HSBC (In-Person, Mumbai)
- September 02, 2026: BOB Capital Markets Ltd (In-Person, Mumbai)
- September 02, 2026: Nirmal Bang (In-Person, Mumbai)
- September 02, 2026: Yes Securities (In-Person, Mumbai)
Additional Notes Section
- The disclosure is a formal regulatory intimation letter addressed to both BSE Limited and National Stock Exchange of India Ltd.
- No financial data, guidance references, or strategic updates were disclosed in this announcement.
- The document was digitally signed by Chirag Kirtibhai Shukla, Company Secretary, on August 27, 2026 at 16:01:01 +05'30'.
- No attachments were mentioned as being included with this filing.